NEW YORK, Oct 17 – Genomic information company Incyte Genomics reported Tuesday third quarter net losses of $7.6 million, or 12 cents per diluted share, compared with a net loss of $11.1 million, or 20 cents per diluted share, for the same period a year ago, meeting Wall Street expectations.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.